Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PP405 topical vehicle gel
- Development stage
- Phase 3
- Lead developer
- Pelage Pharmaceuticals
- Administration
- Topical
01
Overview
PP405 topical vehicle gel is a placebo control formulation used in clinical trials for PP405, a novel topical small molecule developed for the treatment of androgenetic alopecia. The vehicle gel contains the same base formulation as the active drug but without the active ingredient. It serves as a control in clinical studies evaluating the safety and efficacy of PP405.
02
Targets
MPC (Mitochondrial pyruvate carrier)
Beyond the preview
Go deeper on PP405 topical vehicle gel.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PP405 topical vehicle gel.